Recent Events & Catalysts
Novo Nordisk A/S (NVO) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
Agreement Shiftyesterday
NVO analyst agreement shifted
NVO's Committee agreement moved from 42.90% to 57.10% (+14.20pp, 1 day(s) apart).
Score Changeyesterday
NVO committee score rose 1.0 points
NVO's Committee score moved from 47.64 to 48.62 (+0.98, 1 day(s) apart).
Score Change2d ago
NVO committee score fell 2.5 points
NVO's Committee score moved from 50.10 to 47.64 (-2.46, 1 day(s) apart).
Score Change4d ago
NVO committee score fell 0.8 points
NVO's Committee score moved from 50.90 to 50.10 (-0.80, 1 day(s) apart).
Score Change8d ago
NVO committee score fell 0.9 points
NVO's Committee score moved from 49.79 to 48.86 (-0.93, 1 day(s) apart).
Agreement Shift14d ago
NVO analyst agreement shifted
NVO's Committee agreement moved from 50.00% to 42.90% (-7.10pp, 1 day(s) apart).
News
SpaceX's First Earnings Post IPO
SeekingAlpha · today
Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run
SeekingAlpha · 1d ago
Why Is BioAge Labs Stock Sinking Friday?
Benzinga · 1d ago
Novo Nordisk Says Anti-Inflammatory Drug Trial Fails to Cut Cardiovascular Risk in High Risk Patients
Benzinga · 1d ago
Novo Nordisk Announces Ziltivekimab Did Not Translate Into Major Adverse Cardiovascular Events Risk Reduction During Phase 3 Trial In Patients With Atherosclerotic Cardiovascular Disease
Benzinga · 1d ago
Novo Nordisk: Too Late For A Great Opportunity
SeekingAlpha · 2d ago
4 Health Care Stocks With Whale Alerts In Today’s Session
Benzinga · 4d ago
4 Health Care Stocks Whale Activity In Today’s Session
Benzinga · 5d ago
SEC Filings (90 days)
No 8-K filings in the last 90 days.
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.